Andrew D. Goldberg, Director at Tarsus Pharmaceuticals, Inc. (TARS), bought 1,000 shares at $18.96 ($19K) on 2023-12-15, disclosed to the SEC on 2023-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.